Pfizer Inc

MetLife Investment Management, LLC PFE

Report date

12/31/2025

Quarter

2025 Q4

Filed

2/12/2026

Shares

1,362,930

Value ($000)

33,937

Weight

0.2%

2018 Q3 - 2025 Q4 (30 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q4	2/12/2026	33,937	0.2%	1,362,930	12/31/2025
2025 Q3	11/13/2025	35,943	0.2%	1,410,618	9/30/2025
2025 Q2	8/13/2025	35,114	0.2%	1,448,588	6/30/2025
2025 Q1	5/14/2025	37,300	0.2%	1,471,980	3/31/2025
2024 Q4	2/13/2025	39,796	0.2%	1,500,026	12/31/2024
2024 Q3	11/13/2024	42,645	0.2%	1,473,575	9/30/2024
2024 Q2	8/13/2024	42,293	0.3%	1,511,544	6/30/2024
2024 Q1	5/14/2024	36,691	0.2%	1,322,200	3/31/2024
2023 Q4	4/22/2024	39,466	0.3%	1,370,819	12/31/2023
2023 Q3	5/9/2024	46,326	0.4%	1,396,630	9/30/2023
2023 Q2	4/29/2024	52,563	0.4%	1,433,016	6/30/2023
2023 Q1	5/9/2024	59,139	0.4%	1,449,497	3/31/2023
2022 Q4	5/10/2024	75,161	0.6%	1,466,852	12/31/2022
2022 Q3	5/10/2024	65,229	0.6%	1,490,606	9/30/2022
2022 Q2	5/10/2024	79,299	0.6%	1,512,481	6/30/2022
2022 Q1	5/10/2024	79,036	0.5%	1,526,677	3/31/2022
2021 Q4	5/17/2024	73,229	0.6%	1,240,119	12/31/2021
2021 Q3	5/17/2024	54,465	0.5%	1,266,333	9/30/2021
2021 Q2	5/17/2024	50,822	0.5%	1,297,802	6/30/2021
2021 Q1	5/17/2024	48,155	0.5%	1,329,147	3/31/2021
2020 Q4	5/24/2024	49,689	0.5%	1,349,889	12/31/2020
2020 Q3	5/24/2024	51,707	0.6%	1,408,914	9/30/2020
2020 Q2	5/24/2024	47,506	0.5%	1,452,797	6/30/2020
2020 Q1	7/12/2023	46,561	0.7%	1,426,491	3/31/2020
2019 Q4	7/12/2023	57,600	0.6%	1,470,136	12/31/2019
2019 Q3	7/12/2023	54,082	0.6%	1,505,201	9/30/2019
2019 Q2	7/12/2023	66,292	0.7%	1,530,294	6/30/2019
2019 Q1	7/13/2023	67,036	0.8%	1,578,421	3/31/2019
2018 Q4	7/13/2023	72,160	0.9%	1,653,142	12/31/2018
2018 Q3	7/13/2023	75,150	0.8%	1,705,240	9/30/2018